Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients.

Christopher Johns Allen Yen Asal S Rahimi Yu-Lun Liu Ann Marilyn Leitch Ann Spangler Prasanna G Alluri Chika Nwachukwu Rachel Wooldridge Deborah Farr D W Nathan Kim

Published in: Journal of breast cancer (2023)

ASA use during remission was associated with significantly improved OS and DMFS in patients with IBC. These results suggest that ASA may provide survival benefits to patients with IBC. Prospective clinical trials of ASA use in patients with high-risk IBC in remission should be considered.

Keyphrases

clinical trial
disease activity
low dose
ulcerative colitis
oxidative stress
rheumatoid arthritis
antiplatelet therapy
randomized controlled trial
cardiovascular disease
type diabetes
coronary artery disease
acute coronary syndrome
adipose tissue
open label
insulin resistance